Inventor · disambiguated record
Min Wu
Also filed as: WU MIN · Wu min yi
14 granted patents·13 pending applications·209 citations·filing 2004–2024
92Inventor score
Top patents by PatentIndex Score
27 records- 0195US7928120B2Cyanoisoquinoline compounds and methods of use thereofFIBROGEN INC·Filed 2007·Granted Apr 19, 2011·40 cites·36 claims
- 0295US7696223B2Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereofFIBROGEN INC·Filed 2007·Granted Apr 13, 2010·54 cites·32 claims
- 0393US8759373B2Cyanoisoquinoline compounds and methods of use thereofAREND MICHAEL P·Filed 2012·Granted Jun 24, 2014·21 cites·33 claims
- 0493US8269008B2Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditionsAREND MICHAEL P·Filed 2008·Granted Sep 18, 2012·37 cites·32 claims
- 0590US8952160B2Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activityZHOU XIAOTI·Filed 2009·Granted Feb 10, 2015·18 cites·11 claims
- 0688US9387200B2Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activityFIBROGEN INC·Filed 2015·Granted Jul 12, 2016·5 cites·17 claims
- 0788US9174976B2Cyanoisoquinoline compounds and methods of use thereofFIBROGEN INC·Filed 2014·Granted Nov 3, 2015·9 cites·41 claims
- 0880US9409892B24-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitorsFIBROGEN INC·Filed 2013·Granted Aug 9, 2016·6 cites·30 claims
- 0978US7816372B26-cycloamino-2-quinolinone derivatives as androgen receptor modulator compoundsLIGAND PHARM INC·Filed 2004·Granted Oct 19, 2010·11 cites·42 claims
- 1075US12098195B2Anti-IL-23p19 antibody and use thereof in treating diseasesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2019·Granted Sep 24, 2024·1 cites·27 claims
- 1173US2025248995A1Compositions and methods for treating polycythemiaDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 1271US7365178B2Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysisACTIVX BIOSCIENCES INC·Filed 2004·Granted Apr 29, 2008·7 cites·28 claims
- 1371US2024269132A1Compositions and methods for treating polycythemiaDISC MEDICINE INC·Filed 2024·Application pending·0 cites
- 1459US2024417458A1Methods for treating anemia of kidney diseaseDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 1558US2025011455A1ANTI-CD39 Antibody, Preparation Method Therefor And Use ThereofHANGZHOU BANGSHUN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1658US2025049941A1ANTI-CD39 Antibody-Drug Conjugate And Use ThereofSHANGHAI HONGCHENG PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1756US12059061B2Pull-tab extender and methods of useMcraft Leather LLC·Filed 2022·Granted Aug 13, 2024·0 cites·20 claims
- 1856US2011212959A1Cyanoisoquinoline Compounds and Methods of Use ThereofFIBROGEN INC·Filed 2011·Application pending·0 cites
- 1956US2025302823A1Compositions and methods for treating hepatic porphyrias with glycine transport inhibitorsDISC MEDICINE INC·Filed 2023·Application pending·0 cites
- 2055US2007185061A1Heterocyclic boronic acid compoundsCAMPBELL DAVID A·Filed 2006·Application pending·0 cites
- 2154US2016009653A1Cyanoisoquinoline compounds and methods of use thereofFIBROGEN INC·Filed 2015·Application pending·0 cites
- 2253US11692089B2Compositions and additives for degrading plasticGREEN LAND TECH CO INC·Filed 2020·Granted Jul 4, 2023·0 cites·5 claims
- 2353US2024325382A1Compositions and methods for treating anemia associated with a ribosomal disorderDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 2453US2008108642A1Composition and its use as effective constituent of a medicine having anti-angiogenesis synergy effectUNIV TSINGHUA·Filed 2007·Application pending·0 cites
- 2542US11679162B2Anti-5T4 antibody-drug conjugate and use thereofHANGZHOU ADCORIS BIOPHARMA CO LTD·Filed 2018·Granted Jun 20, 2023·0 cites·20 claims
- 2642US2020325156A1Heteroaryl amide compounds, preparation method therefor, pharmaceutical compositions thereof, and applications thereofRUI JIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE·Filed 2018·Application pending·0 cites
- 2738US2021338842A1Dual-modality nanoprobe targeting glioblastoma and preparation method thereofWEST CHINA HOSPITAL OF SICHUAN UNIV·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Min Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →